10 Results (showing 1 - 10)
Toolkit for hospital teams working with NAS.
Explores a study on the potential effect long-acting buprenorphine injectables.
Explores the effect changes to methadone treatment protocols for opioid use disorder in response to the COVID-19 pandemic have had on access to treatment in rural areas.
This 2018 webinar from the National Conference of State Legislators presents information on opiiods and early adversity and discusses childhood trauma and addiction. It also presents examples of successes in Tennesee and Vermont.
This document developed by SAMHSA provides brief summaries of substance abuse prevention strategies and associated programs that have been evaluated to determine their effects on the nonmedical use of prescription drugs (NMUPD.) It should be considered a resource for state and community prevention practitioners seeking information on interventions to reduce NMUPD
A resource for professionals about the developmental impact of trauma. Includes the symptoms of trauma and interventions for different age groups, as well as the impact of trauma on brain development.
The five readiness tools in this guide were developed to support your efforts to successfully assess, plan, and identify emerging consortium needs. These brief tools emphasize (1) planning consortium engagement (motivation), (2) determining necessary tasks and activities, and (3) identifying specific capacities (abilities) to carry out these tasks for the Rural Communities Opioid Response Program-Planning (RCORP-P) initiative.
A general resource for medical professionals that describes the history and impact of opioid prescribing, criteria for diagnosis of opioid disorder, and treatment of opioid use disorder. Includes information about Medication Assisted Treatment,Cognitive Based Therapy and Contingency Management.
This fact sheet offers practical suggestions physicians can use in general pediatric offices to identify, treat, and refer adolescent patients who may be misusing or abusing opioids.
This resource is a white paper produced by the Office of the Assistant Secretary for Planning and Evaluation about policy levers for expanding family-centered medication assisted treatment. The white paper contains the program framework, findings from a state program scan, findings from interviews, challenges, opportunities and recommendations.